From the Wuhan-Hu-1 strain to the XD and XE variants: is targeting the SARS-CoV-2 spike protein still a pharmaceutically relevant option against COVID-19?우한-Hu-1 변종에서 XD 및 XE 변종까지: SARS-CoV-2 스파이크 단백질을 표적으로 하는 것이 여전히 COVID-19에 대한 약학적으로 적절한 옵션입니까?Article Published on 2022-12-012022-09-11 Journal: Journal of Enzyme Inhibition and Medicinal Chemist [Category] [DOI] 10.1080/14756366.2022.2081847 PMC 바로가기 [Article Type] Article
Delta Infection After Vaccination Elicits Potent Neutralizing Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 OmicronArticle Published on 2022-11-012022-11-15 Journal: The Journal of Infectious Diseases [Category] [DOI] 10.1093/infdis/jiac149 PMC 바로가기
Antibody and T-cellular response to COVID-19 booster vaccine in SARS-CoV-1 survivorsArticle Published on 2022-11-012022-11-15 Journal: Clinical immunology (Orlando, Fla.) [Category] [DOI] 10.1016/j.clim.2022.109103 PMC 바로가기
Immunogenicity of Third-dose BNT162b2 mRNA Vaccine Following Two Doses of ChAdOx1 in Health Care Workers: A Prospective Longitudinal StudyArticle Published on 2022-11-012022-11-16 Journal: Annals of laboratory medicine [Category] [DOI] 10.3343/alm.2022.42.6.688 PMC 바로가기
An antibody from single human VH-rearranging mouse neutralizes all SARS-CoV-2 variants through BA.5 by inhibiting membrane fusionArticle Published on 2022-10-282022-11-15 Journal: Science Immunology [Category] [DOI] 10.1126/sciimmunol.add5446 PMC 바로가기
Computational Design and Experimental Validation of ACE2-Derived Peptides as SARS-CoV-2 Receptor Binding Domain InhibitorsArticle Published on 2022-10-202022-11-16 Journal: The journal of physical chemistry. B [Category] [DOI] 10.1021/acs.jpcb.2c03918 PMC 바로가기
A Bivalent Omicron-Containing Booster Vaccine against Covid-19Article Published on 2022-10-062022-11-15 Journal: The New England Journal of Medicine [Category] [DOI] 10.1056/NEJMoa2208343 PMC 바로가기
Humoral immunity to SARS-CoV-2 elicited by combination COVID-19 vaccination regimensArticle Published on 2022-10-032022-11-15 Journal: The Journal of Experimental Medicine [Category] [DOI] 10.1084/jem.20220826 PMC 바로가기
Permissive omicron breakthrough infections in individuals with binding or neutralizing antibodies to ancestral SARS-CoV-2Article Published on 2022-09-292022-11-15 Journal: Vaccine [Category] [DOI] 10.1016/j.vaccine.2022.08.058 PMC 바로가기
Comparative analysis of the neutralizing activity against SARS-CoV-2 Wuhan-Hu-1 strain and variants of concern: Performance evaluation of a pseudovirus-based neutralization assayArticle Published on 2022-09-262022-11-15 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2022.981693 PMC 바로가기